Alphamab Oncology Announces the Results of a Phase III Clinical Study of Anbenitamab (KN026) were Published in Annals of Oncology SUZHOU, China, Jan. 27, 2026 /PRNewswire/ — Alphamab Oncology (Stock Code: 9966.HK) announced… CISION PRNewswireJanuary 27, 2026
Press Release ICP DAS-BMP at WHX Dubai 2026 Spotlights Low-Migration and Low-Friction TPU HSINCHU, Jan. 27, 2026 /PRNewswire/ — ICP DAS-BMP (Biomedical Polymers), a Taiwan-based… CISION PRNewswireJanuary 27, 2026
Press Release New "MedTech Advance" Sourcing Directory Launches to Streamline Global Medical Device Manufacturing Comprehensive e-book accelerates product development by connecting R&D and procurement teams with… CISION PRNewswireJanuary 27, 2026
REALTY ONE GROUP CELEBRATES 20 YEARS OF COMMUNITY IMPACT, REPORTS STRONG 2025 GIVING RESULTS LAGUNA NIGUEL, Calif., Jan. 27, 2026 /PRNewswire/ — Realty ONE Group International,… CISION PRNewswireJanuary 27, 2026
Press Release Heartbeats Shareholder Mr Lu Min Yong Honoured as "Global Chinese Role Model" at the 2026 Spring Festival Gala Evening SYDNEY and BEIJING, Jan. 27, 2026 /PRNewswire/ — Heartbeats proudly congratulates its… CISION PRNewswireJanuary 27, 2026
Innovent Announces IBI3003 (GPRC5D/BCMA/CD3 Trispecific Antibody) Receives Fast Track Designation from the U.S. FDA for Relapsed or Refractory Multiple Myeloma SAN FRANCISCO and SUZHOU, China, Jan. 27, 2026 /PRNewswire/ — Innovent Biologics, Inc.… CISION PRNewswireJanuary 27, 2026
Reeracoen Study Finds Malaysian Employers Taking a More Targeted Approach to Hiring in 2026 Tighter labor market and rising costs prompt shift toward skills-aligned recruitment KUALA… CISION PRNewswireJanuary 27, 2026
Press Release WireBarley Partners with LAFC in First Deal for Korean Fintech SEOUL, South Korea, Jan. 27, 2026 /PRNewswire/ — Global fintech company WireBarley has… CISION PRNewswireJanuary 27, 2026
